Princeton Alpha Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-45,086
Closed -$1.51M 890
2016
Q2
$1.51M Buy
+45,086
New +$1.44M 0.27% 88
2015
Q3
Sell
-54,708
Closed -$1.74M 863
2015
Q2
$1.74M Buy
+54,708
New +$1.78M 0.34% 71
2015
Q1
Sell
-22,233
Closed -$657K 843
2014
Q4
$657K Sell
22,233
-8,599
-28% -$247K 0.19% 144
2014
Q3
$865K Sell
30,832
-31,535
-51% -$885K 0.2% 134
2014
Q2
$1.76M Buy
+62,367
New +$1.78M 0.36% 66
2014
Q1
Sell
-23,443
Closed -$681K 709
2013
Q4
$681K Buy
+23,443
New +$682K 0.5% 24

Other funds holding PFE

Princeton Alpha Management's PFE Position: Q3 2016 in Review

Princeton Alpha Management sold out of Pfizer (PFE) in Q3 2016, closing a stake of 45,086 shares — an estimated $1.51M sold.

Princeton Alpha Management first reported a position in PFE in Q4 2013 and held it in 6 quarters. The position peaked at $1.76M in Q2 2014. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Princeton Alpha Management reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 45,086 Pfizer shares in Q3 2016, an estimated $1.51M.
  • Princeton Alpha Management first reported a position in Pfizer in Q4 2013 and held it in 6 quarters.
  • Princeton Alpha Management's Pfizer position peaked at $1.76M in Q2 2014.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Princeton Alpha Management's 13F filing for Q3 2016, filed 10 Nov 2016.